Acorda Therapeutics (ACOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACOR | ZVSA | BDRX | ||
| Company | Acorda Therapeutics | Zyversa Therapeutics Inc | Biodexa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.7800 | 1.1400 | 4.30 | ||
| High | 0.8500 | 1.1800 | 7.47 | ||
| Low | 0.6116 | 1.1100 | 4.18 | ||
| Last | 0.6610 | 1.1400 | 4.40 | ||
| Change | -0.2187 | -0.0100 | +0.55 | ||
| % Change | -24.86% | -0.87% | +14.29% | ||
| Volume | 416,900 | 243,400 | 5,813,500 | ||
| 20-Day Average Volume | 396,280 | 3,573,820 | 333,200 | ||
| Previous Close | 0.8797 | 1.1500 | 3.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.1538 | 1.5881 | 5.23 | ||
| 20-Day Raw Stochastic | 0.37% | 4.29% | 22.67% | ||
| 20-Day Relative Strength | 20.79% | 33.50% | 38.60% | ||
| Weighted Alpha | -37.54 | -92.74 | -93.07 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 24% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -60.65% since 04/04/24 | +0.88% since 11/14/24 | -9.47% since 11/14/24 | ||
| Low | 0.6116 on 04/11/24 | 1.0401 on 11/15/24 | 3.50 on 11/19/24 | ||
| High | 1.6214 on 04/05/24 | 1.2899 on 11/19/24 | 7.47 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -94.49% since 03/11/24 | -50.43% since 10/21/24 | -26.42% since 10/21/24 | ||
| Low | 0.6116 on 04/11/24 | 1.0401 on 11/15/24 | 3.50 on 11/19/24 | ||
| High | 14.1100 on 03/15/24 | 3.3700 on 11/05/24 | 7.47 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | -95.96% since 01/11/24 | -69.52% since 08/21/24 | -72.50% since 08/21/24 | ||
| Low | 0.6116 on 04/11/24 | 1.0401 on 11/15/24 | 3.50 on 11/19/24 | ||
| High | 18.0000 on 01/18/24 | 3.9600 on 08/22/24 | 16.00 on 08/26/24 | ||
| 6-Month | |||||
| %Chg | -93.85% since 10/11/23 | -74.09% since 05/21/24 | -92.45% since 05/21/24 | ||
| Low | 0.6116 on 04/11/24 | 1.0401 on 11/15/24 | 3.50 on 11/19/24 | ||
| High | 18.0000 on 01/18/24 | 6.3000 on 07/10/24 | 42.50 on 05/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 821 | 1,185 | 458 | ||
| Shares Outstanding, K | 1,242 | 1,030 | 119 | ||
| Annual Sales | 117,630,000 | 0 | 410,000 | ||
| Annual Net Income | -252,850,000 | -98,300,000 | -7,660,000 | ||
| Last Quarter Sales | 37,990,000 | 0 | N/A | ||
| Last Quarter Net Income | -217,760,000 | -2,400,000 | N/A | ||
| 60-Month Beta | 1.40 | 0.65 | 1.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -175.32 on 04/01/24 | -2.43 on 11/14/24 | N/A | ||
| Latest Earnings Date | 05/09/24 | 11/12/24 | 04/26/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||